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Abstract  
1-(2-hydroxy-3,4-benzophenyl-5-methoxy)-3aryl-prop-2-ene-1-one &  semicarbazide / thiosemicarbazide / phenylhydrazine 
/isonicotinic acid hydrazide were added to DMF and the mixture was refluxed for about 2 hours . The reaction mixture was 
cooled and diluted with water. The semisolid so obtained was triturated  with ethanol to get a solid which was  
recrystallised from ethanol–acetic acid mixture to obtain titled pyrazolines  
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INTRODUCTION 
 
     Pyrazoline Derivatives having five  membered  heterocyclic  
compounds are known to be biologically active and are important 
constituents of many pharmaceutical and agrochemical products. 
Pyrazolines and  isoxazoles have been found to be established  
that  introduction  of  thiophenyl group associated with diverse  
biological  activities  and numerous  reports  have  appeared in  
the literature which highlighted  their  chemistry and use. Pyrazole 
derivatives were  known to possess  many biological derivatives 
including antibacterial1 antifungal2 antiinflammatory anti-depressant4 
anti-tumor5 musclerelaxant6 anti-arthritic7 analgesic8 and 
anticonvulsant9 properties Also,  varied  medicinal  activities such 
as anti-inflammatory10 antibacterial 11 Anticonvulsan12, antibiotic13 
anti-tubercular14 antiungal15 and  anxiolytic  activity16  
     Heterocyclic compounds containing nitrogen are widely 
distributed in nature and play an important role in the metabolism of 
all living cells. Present work deals with the synthesis of 3-(2-
hydroxy–3,4-benzophenyl-5-methoxy)-5-aryl–1-substituted 
Pyrazolines  and their characterization by elemental analysis, IR, 
1H NMR analysis. 
 
EXPERIMENTAL 
 
     All the melting points were taken in silicon oil bath with open 
capillary tubes and are uncorrected. IR spectra were recorded on a 
Nicolet-Impact 400 FT-IR spectrometer .  1 H NMR spectra were 
recorded on a Brucker AC300 FNMR spectrometer (300 MHz), using 
TMS as an internal standard. Microanalysis of nitrogen was obtained 
on Colman 29-N analyzer. Thin Layer Chromatography on silica gel-
G, was used to check the  purity of the compounds. 
Synthesis of 2-Acetyl- 4 methoxy-1-naphthol 
2-Acetyl- 4 methoxy-1-naphthol was prepared by refluxing 4-methoxy 
-1-naphthol with glacial acetic acid in presence of fused ZnCl2. 
Synthesis of 1-(2-Hydroxy-3,4-benzophenyl-5-methoxy)-3-aryl-prop-
2-ene-1-one  
1 - ( 2 -Hydroxy -3 ,4 -benzophenyl-5 -methoxy) -3-aryl –prop -2-ene 
-1-one  were  synthesized from 2-acetyl-4-methoxy-1-naphthol by 
condensing it with aromatic aldehydes. 
Synthesis of 3-(2-hydroxy–3,4-benzophenyl-5-methoxy)-5-(4-
methoxy phenyl)–1-substituted Pyrazolines.  
      1-(2-hydroxy-3,4-benzophenyl-5-methoxy)-3aryl-prop-2-ene-1-
one &  semicarbazide / thiosemicarbazide phenylhydrazine 
/isonicotinic acid hydrazide were added to DMF and the mixture was 
refluxed for about 2 hours . The reaction mixture was cooled and 
diluted with water. The semisolid so obtained was triturated  with 
ethanol to get a solid which was  recrystallised from ethanol–acetic 
acid mixture to obtain titled pyrazolines  
Spectral interpretation of (4a) 
IR (νmax) (cm-1):  3418(-OH str.)  1320 (C-O-C ) , 1570 (C=N str), 
 
NMR (δ ppm): 3.85 (s, 3H, OCH3 ), 3.82 (S, 3H, OCH3), 11.71 (s, 1H, 
OH), 5.15 (d, 1H, - CH , J= 12Hz), 6.09 (d, 1H,   - CH , J= 12Hz)   
6.52-8.3 (m , 14 H, Ar-H )  
 
Spectral interpretation of (4b) 
 
IR (νmax) (cm-1):  3430(-OH str.)  1650  (C=O str),  3218 (NH2 
str.), 1325(C-O-C ) , 1572 (C=N str) 
 
NMR (δ ppm): 3.80 (s, 3H, OCH3 ), 3.83 (3H, OCH3),   6.66-7.44 
( m,  9 H,  Ar-H) , 7.64 (s, 2H,   -NH2), 11.75 (s, 1H, OH) 5.15 (d, 
1H,  CH , J= 12Hz), 6.09 (d, 1H, CH , J= 12Hz)           
 
Spectral interpretation of (4c) 
 
IR (νmax) (cm-1):  3345 (OH str),  1322(C-O-C ) , 1565 (C=N str), 
3212 (NH2 str.) 
NMR (δ ppm): 3.80 (s, 3H, OCH3 ), 3.83 (3H, OCH3),  7.69 (s, 2H, -
NH2), 11.78 (s, 1H, OH)              
5.15 (d, 1H, CH , J= 12Hz), 6.09 (d, 1H,CH, J= 12Hz) , 6.52-8.3 
(m ,9 H, Ar-H)  
 
Spectral interpretation of (4d) 
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IR (νmax) (cm-1):  3390 (OH str), 1636 (C=O str) 1572,  (C=N str), 
1330 (C-O-C )  
 
NMR (δ ppm): 3.80 (s, 3H, OCH3 ), 3.83 (3H, OCH3),  5.13 (d, 1H,  
- CH, J= 12Hz ), 6.10 (d, 1H,  - CH, J= 12Hz),  7.41-7.88 (m , 14H, 
Ar-H ), 12.47( s, 1H, OH) 
 
Table 1. Physical data of synthesized compounds. 
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